bloom glp 1 Five Unexpected New Uses for GLP-1 Receptor Agonists Pros & Cons of GLP-1

Once you know the big pharmaceutical companies are spending a lot of money looking for glucagon receptor antagonists and testing them, and GIP receptor antagonists and testing them, it requires a lot of gusto, a lot of lunacy and craziness to say, nah, I believe all these big pharmaceutical companies are wrong, my lab is doing the opposite. But now, the sentiment has drastically shifted and many companies are looking to co-agonist drugs to achieve over 20%, or even close to 30% weight loss

Risk of allcause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network

pancreatitis cases classified by cause: drug-induced, alcohol-related, triglyceride-related, biliary, or idiopathic

Phentermine was designed as a short-term intervention

95% CI, 0.41 to 0.76) respectively [74]

Obesity and insulin resistance are the main factors that cause this reduced fertility [21-23]